This website is for the U.S, for the other countries please refer to this link.
SUDOSCAN UTILITY TO DETECT FOOT SUDOMOTOR DYSFUNCTION IN TYPE 1 DIABETES WITHOUT CLINICAL EVIDENCE OF PERIPHERAL NEUROPATHY Danyelle Lorrane Carneiro Veloso, Raira Castilho Gomes Nascimento,
CLINICAL IMPACT OF DPP-4 INHIBITOR ON AUTONOMIC NEUROPATHY FOLLOWED UP BY SUDOSCAN A. Syngle, S. Chahal, K. Vohra. Article title: Efficacy and tolerability of DPP4
SUDOSCAN COMBINED TO OTHER DIAGNOSIS TESTS TO CONFIRM SMALL FIBER NEUROPATHY V. Fabry, A. Gerdelat, B. Acket, P. Cintas, V. Rousseau, E. Uro-Coste, S.
SUCCESSFUL WEB CONFERENCE ON SUDOSCAN UTILITY IN DIABETES On July the 10th Impeto Medical has organized a web conference for diabetologists: Management of diabetic foot
THE UTILITY OF SUDOSCAN TO DIAGNOSE DIABETIC CARDIOVASCULAR AUTONOMIC NEUROPATHY AND DIABETIC POLYNEUROPATHY C. D’amato, C. Greco, G. Lombardo, V. Frattina, M. Campo, C.M.A. Cefalo,
THE BENEFITS OF SUDOSCAN IN EARLY DIAGNOSIS OF DIABETIC PERIPHERAL NEUROPATHY REVIEWED IN THE LANCET Selvarajah D, Kar D, Khunti K, Davies MJ, Scott AR,
Promotional Communication. The medical devices SUDOSCAN is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12
